Updates from FDA

APhA staff

Roughly 12% of pediatric patients are prescribed psychotropic medications, with vulnerable populations—such as those in foster care—prescribed these medications at even higher rates.

Loren Bonner

Results from the ASPREE randomized, double-blind clinical trial, which were published in the July 2023 issue of the Annals of Internal Medicine, validated the concept that aspirin at low doses may cause damage to the GI tract.

Clarissa Chan, PharmD

For many people, GI issues can cause significant disruptions to their daily lives. Belching, abdominal bloating, and distention are some of the primary symptoms that cause discomfort and can lead patients to seek care with a gastroenterologist.

Olivia C. Welter, PharmD

As health concerns over anxiety and stress levels have grown in recent years, sales of ashwagandha have also soared as demand spiked for supplements addressing mood and stress.

Mickie Cathers